Document 0325
 DOCN  M9440325
 TI    Advances in the treatment of superficial candida infections.
 DT    9404
 AU    Goldstein SM; Department of Dermatology, University of California, San;
       Francisco 94143-0536.
 SO    Semin Dermatol. 1993 Dec;12(4):315-30. Unique Identifier : AIDSLINE
       MED/94145865
 AB    This article reviews recent controlled studies of treatment for candida
       infections of the skin and mucous membranes. In general, excellent
       agents are available for treatment, with reasonable alternatives for the
       uncommon emergence of resistant strains. Cutaneous infections in
       immunocompetent patients are effectively treated with topical agents.
       The major clinical problems that remain include frequently recurrent
       vulvovaginal candidiasis, and oroesophageal candida infections in
       patients with malignancies and immunosuppression. These often require
       systemic therapy. A number of treatment strategies have been
       investigated and are reviewed.
 DE    Acquired Immunodeficiency Syndrome/COMPLICATIONS  Administration,
       Cutaneous  Administration, Oral  Adult  Antifungal
       Agents/ECONOMICS/PHARMACOLOGY/*THERAPEUTIC USE  Biological Availability
       Candidiasis/COMPLICATIONS/*DRUG THERAPY/IMMUNOLOGY  Chronic Disease
       Comparative Study  Drug Interactions  Drug Resistance, Microbial  Female
       Human  Infant  Male  Neoplasms/MICROBIOLOGY  Onychomycosis/DRUG
       THERAPY/MICROBIOLOGY  Paronychia/DRUG THERAPY/MICROBIOLOGY  Penile
       Diseases/DRUG THERAPY/MICROBIOLOGY  Recurrence  CLINICAL TRIAL  JOURNAL
       ARTICLE  RANDOMIZED CONTROLLED TRIAL  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).